Brief: Heart Test Laboratories Inc Says On Track For MyoVista FDA De Novo Resubmission In Current Fiscal Year

HeartSciences

13/09/2022 14:20

Sept 13 (Reuters) - Heart Test Laboratories Inc  HSCS.O :
    * HEART TEST LABORATORIES INC - REMAINS ON TRACK FOR
MYOVISTA® FDA
DE NOVO RESUBMISSION IN CURRENT FISCAL YEAR
    * HEART TEST LABORATORIES INC - NEARING COMPLETION OF
PATIENT
RECRUITMENT IN FDA PIVOTAL CLINICAL VALIDATION STUDY OF
MYOVISTA®
    * HEART TEST-CONTINUES TO CAREFULLY MANAGE EXPENSES &
BELIEVES HAS
SUFFICIENT CAPITAL TO SUPPORT OPERATIONS BEYOND RESUBMISSION FOR
FDA DE NOVO CLEARANCE

Source text for Eikon:  ID:nGNE4pLtdZ 
Further company coverage:  HSCS.O 

 ((Reuters.Briefs@thomsonreuters.com;))